Please provide a diagram of hepatitis B infection showing the timing of appearance and disappearance of the viral antigens and corresponding antibodies.

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 9, 2026 • View editorial policy

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.

Hepatitis B Infection: Serologic Markers Timeline

The appearance and disappearance of hepatitis B antigens and antibodies follows a predictable temporal pattern that is essential for diagnosis and monitoring. 1

Acute Hepatitis B Infection Timeline

Early Phase (0-6 weeks post-exposure)

  • HBV DNA appears first, detectable 10-20 days before HBsAg 2
  • HBsAg becomes detectable at average 30 days (range: 6-60 days) after exposure 2
  • HBsAg is the only marker present during the first 3-5 weeks 2

Active Infection Phase (1-6 months)

  • Anti-HBc (IgM and IgG) appears 1-2 weeks after HBsAg detection 1
  • HBeAg appears during active viral replication, indicating high infectivity 1
  • HBsAg persists throughout acute infection
  • IgM anti-HBc remains detectable for up to 6 months 1

Recovery Phase (3-6 months)

  • HBsAg disappears typically 4-6 months after infection onset 3
  • Anti-HBe appears as viral replication decreases 1
  • "Window period" may occur: HBsAg negative but anti-HBs not yet detectable; only anti-HBc IgM is present 3
  • Anti-HBs develops typically within 3-4 months after HBsAg clearance 1

Long-term (>6 months)

  • IgG anti-HBc persists for life 1
  • Anti-HBs indicates immunity and persists long-term 1
  • IgM anti-HBc becomes undetectable within 6 months 1

Chronic Hepatitis B (>6 months HBsAg positive)

If HBsAg persists beyond 6 months, spontaneous clearance is unlikely and infection is deemed chronic 1

Chronic Infection Markers:

  • HBsAg remains positive indefinitely
  • Total anti-HBc positive (IgG predominates)
  • IgM anti-HBc negative (unless acute exacerbation)
  • Anti-HBs negative
  • HBV DNA positive 1

HBeAg Status in Chronic Infection:

  • HBeAg-positive: High viral replication (typically >20,000 IU/mL) 4
  • HBeAg-negative with anti-HBe: Lower viral replication (often 2,000-20,000 IU/mL) 4

Key Serologic Patterns Summary Table

Marker Acute Infection Recovery Chronic Infection Vaccination
HBsAg Positive Negative Positive Negative
Anti-HBs Negative Positive Negative Positive
Total anti-HBc Positive Positive Positive Negative
IgM anti-HBc Positive Positive/Negative Negative Negative
HBV DNA Positive Negative Positive Negative

1

Critical Clinical Pearls

Common pitfalls to avoid:

  1. Transient HBsAg positivity can occur up to 18 days post-vaccination (52 days in hemodialysis patients) and is clinically insignificant 1

  2. Isolated anti-HBc (only marker present) can represent:

    • Resolved infection with waned anti-HBs
    • Occult chronic infection (HBV DNA detectable in <10% of cases)
    • False-positive result 1
  3. Window period diagnosis: During the serologic window when both HBsAg and anti-HBs are negative, anti-HBc IgM is the only detectable marker and confirms acute infection 3

  4. Vaccination vs. natural immunity: Anti-HBs alone (without anti-HBc) indicates vaccine-derived immunity; both anti-HBs and anti-HBc indicate natural infection recovery 1

  5. HBeAg presence correlates with high viral replication and increased infectivity, while anti-HBe generally indicates lower viral replication 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.